Adjuvatis develops, manufactures biocompatible delivery system called i-Particles® and proposes a formulation service based on its technology.
Fully metabolizable i-Particles
i-Particles® technology originates from the fundamental statement that pharmaceuticals should never involve harmful by-products and only focus on patient safety. Starting from this idea, Adjuvatis technology is led by one main concept: safe-by-design.
Synthetized by an eco-friendly and additive-free process, i-Particles® exclusively consist in a biodegradable polymer and selected active pharmaceutical ingredients.
Increasing pharmaceutical efficacy and safety while reducing risk profile and costs, and extending product life cycle.
Following 10 years of research and supported by a multi-skilled team, Adjuvatis will push forward your active’s intrinsic properties and potentiate your product development.
i-Particles - Driver of innovation
i-Particles® formulations have demonstrated enhancements in healthcare and technological fields, especially vaccines, antibody generation and drug delivery. Adjuvatis is constantly extending the scope of applications to reach new markets, support customer developments and prove once again the versatility of its technology.
i-Particles-based formulations & in-depth characterizations
Adjuvatis provides a full formulation development and characterization services in a rigorous quality framework.
What are you waiting for?
Discover our fully dedicated and quality-oriented ways of working, integrating both skills and experience to provide cutting-edge service for formulation development of biopharmaceuticals.
Our dynamic team, supported by a referent advisory board and external experts, qualifies for expertise in Chemistry, Biochemistry and Biology, Manufacturing and Partnering. By working collaboratively, we are committed to innovate for your therapeutic products developments.
Follow our participation to scientific events, symposium and congresses.
Discover our press releases and publications.
Welcome in Lyon
At the heart of the Biodistrict Lyon Gerland, a hotspot for world leaders in Life Sciences in vicinity to institutional, academic and private companies, Adjuvatis benefits from a unique environment in terms of technological innovation.